| Age (years) | Weight (kg) | Height (m) | BSA (m2) | Height z-score | |||||
---|---|---|---|---|---|---|---|---|---|---|
 | Coefficient | p-value | Coefficient | p-value | Coefficient | p-value | Coefficient | p-value | Coefficient | p-value |
Age or size factor | −6.6 | 0.01* | −5.9 | 0.01* | −135.3 | 0.001 ** | −221.3 | 0.01* | −70.8 | 0.02* |
Sex (vs female) | −46.4 | 0.05* | −45.7 | 0.05 | −45.1 | 0.05 | −45.2 | 0.06 |  |  |
Indication for testing (vs GH sufficient short stature) | ||||||||||
GHD | Â | NS | Â | NS | Â | NS | Â | NS | Â | NS |
Concern for multi-pituitary abnormalities | −67 | 0.05* | −137 | 0.06 | −63 | 0.06 | −173 | 0.07 |  | NS |
Neoplasm with risk to pituitary | Â | NS | Â | NS | Â | NS | Â | NS | Â | NS |
Exogenous glucocorticoid exposure | −249 | <0.0005** | −398 | <0.0005** | −242 | <0.0005** | −425 | <0.0005** |  | NS |
Known multi-pituitary abnormalities | −104 | 0.02* | −244.0 | 0.03* | −94 | 0.04* |  | NS |  | NS |
Interaction variables (vs GH sufficient group*age or size factor) | ||||||||||
GHD*(age or size factor) | Â | Â | Â | NS | Â | Â | Â | NS | Â | NS |
Concern for multi-pituitary*(age or size factor) | Â | Â | Â | NS | Â | Â | Â | NS | Â | NS |
Neoplasm*(age or size factor) | Â | Â | Â | NS | Â | Â | Â | NS | Â | NS |
Exogenous glucocorticoids*(age or size factor) | Â | Â | 6.4 | 0.02* | Â | Â | 212 | 0.05* | 129.3 | <0.0005** |
Known multi-pituitary*(age or size factor) | Â | Â | Â | NS | Â | Â | Â | NS | Â | NS |
Baseline cortisol (nmol/L) | 0.59 | <0.0005** | 0.60 | <0.0005** | 0.58 | <0.0005** | 0.60 | <0.0005** | 0.65 | <0.0005** |
Peak ACTH (pmol/L) | 2.56 | <0.0005** | 2.49 | <0.0005** | 2.47 | <0.0005** | 2.49 | <0.0005** | 2.20 | <0.0005** |
R2, n | 0.5092, 222 | 0.5201, 222 | 0.5182, 222 | 0.5196, 222 | 0.5481, 222 |